Cellibre Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 20

Cellibre General Information

Description

Operator of a cellular agriculture company intended to develop sustainable biological products. The company employs an organism-agnostic approach, precision fermentation, AI-driven enzyme and protein engineering, and high-throughput strain and bioprocess optimization, enabling pharmaceutical, functional health, beauty, and nutraceutical companies to access scalable, lower-cost, higher-quality ingredients while reducing reliance on agriculture and strengthening supply chain resilience.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10581 Roselle Street
  • Suite 100
  • San Diego, CA 92121-1519
  • United States
+1 (412)
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Corporate Office
  • 10581 Roselle Street
  • Suite 100
  • San Diego, CA 92121-1519
  • United States
+1 (412)

Cellibre Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellibre Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 22-Oct-2025 Completed Generating Revenue
5. Later Stage VC (Series A) 08-Oct-2024 Completed Generating Revenue
4. Grant 12-Jul-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 07-Sep-2021 Completed Generating Revenue
2. Early Stage VC (Series A2) 05-Oct-2020 $8.4M $8.4M Completed Generating Revenue
1. Debt - PPP 01-May-2020 $288K Completed Generating Revenue
To view Cellibre’s complete valuation and funding history, request access »

Cellibre Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2-1
Series A2
Series A-3
Series A-2
Series A-1 108,290 $0.000010 8% $29.41 $29.41 1x $29.41 3.82%
Series A 326,502 $0.000010 8% $38.67 $38.67 1x $38.67 11.52%
To view Cellibre’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellibre Patents

Cellibre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025160464-A1 Engineered cells and methods for the synthesis of caffeoyltyramine and feruloyltyramine Pending 26-Jan-2024
AU-2024308825-A1 Enzymes and methods for the synthesis of bakuchiol and derivatives Pending 30-Jun-2023
EP-4735589-A2 Enzymes and methods for the synthesis of bakuchiol and derivatives Pending 30-Jun-2023
WO-2025007156-A2 Enzymes and methods for the synthesis of bakuchiol and derivatives Inactive 30-Jun-2023
WO-2025007156-A3 Enzymes and methods for the synthesis of bakuchiol and derivatives Inactive 30-Jun-2023 C12N9/1085
To view Cellibre’s complete patent history, request access »

Cellibre Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellibre Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dellin Investments PE/Buyout Minority
Symrise Corporation Minority
Verdant Ventures (Seattle) Venture Capital Minority
JourneyOne Ventures Venture Capital Minority
National Center For Complementary And Integrative Health Government
You’re viewing 5 of 20 investors. Get the full list »

Cellibre FAQs

  • When was Cellibre founded?

    Cellibre was founded in 2017.

  • Where is Cellibre headquartered?

    Cellibre is headquartered in San Diego, CA.

  • What is the size of Cellibre?

    Cellibre has 29 total employees.

  • What industry is Cellibre in?

    Cellibre’s primary industry is Biotechnology.

  • Is Cellibre a private or public company?

    Cellibre is a Private company.

  • What is Cellibre’s current revenue?

    The current revenue for Cellibre is .

  • How much funding has Cellibre raised over time?

    Cellibre has raised $30.1M.

  • Who are Cellibre’s investors?

    Dellin Investments, Symrise, Verdant Ventures (Seattle), JourneyOne Ventures, and National Center For Complementary And Integrative Health are 5 of 20 investors who have invested in Cellibre.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process